Your browser doesn't support javascript.
loading
Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma.
Yamamoto, Yoshiaki; Yatsuda, Junji; Shimokawa, Mototsugu; Fuji, Nakanori; Aoki, Akihiko; Sakano, Shigeru; Yamamoto, Mitsutaka; Suga, Akinobu; Tei, Yasuhide; Yoshihiro, Satoru; Kitahara, Seiji; Nagao, Kazuhiro; Takai, Kimio; Kamiryo, Yoriaki; Akao, Jumpei; Yamaguchi, Shiro; Oba, Kazuo; Shimabukuro, Tomoyuki; Matsumoto, Hiroaki; Kamba, Tomomi; Matsuyama, Hideyasu.
Afiliación
  • Yamamoto Y; Department of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi, 755-8505, Japan.
  • Yatsuda J; Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Shimokawa M; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Fuji N; Department of Urology and Nephrology, Tokuyama Central Hospital, Shunan, Japan.
  • Aoki A; Department of Urology, Masuda Red Cross Hospital, Masuda, Japan.
  • Sakano S; Department of Urology, Kokura Memorial Hospital, Kitakyusyu, Japan.
  • Yamamoto M; Department of Urology, Yamaguchi Grand Medical Center, Hofu, Japan.
  • Suga A; Department of Urology, Yamaguchi Red Cross Hospital, Yamaguchi, Japan.
  • Tei Y; Department of Urology, Kanmon Medical Center, 1-1-1, Shimonoseki, Japan.
  • Yoshihiro S; Department of Urology, Shimonoseki City Hospital, Shimonoseki, Japan.
  • Kitahara S; Department of Urology, Sanyo-Onoda Municipal Hospital, Sanyo-Onoda, Japan.
  • Nagao K; Department of Urology, Shuto General Hospital, Yanai, Japan.
  • Takai K; Department of Urology, Saiseikai Shimonoseki General Hospital, Shimonoseki, Japan.
  • Kamiryo Y; Department of Urology, Shimonoseki Saiseikai Toyoura Hospital, Shimonoseki, Japan.
  • Akao J; Department of Urology, Ogori Daiichi General Hospital, Yamaguchi, Japan.
  • Yamaguchi S; Department of Urology, Shimonoseki Medical Center, Shimonoseki, Japan.
  • Oba K; Department of Urology, Saiseikai Yamaguchi General Hospital, Yamaguchi, Japan.
  • Shimabukuro T; Department of Urology, Ube-kohsan Central Hospital Corp, Ube, Japan.
  • Matsumoto H; Department of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi, 755-8505, Japan.
  • Kamba T; Department of Urology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Matsuyama H; Department of Urology, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi, 755-8505, Japan. hidde@yamaguchi-u.ac.jp.
Int J Clin Oncol ; 26(1): 169-177, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32948925
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Neutrófilos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos / Neutrófilos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón